• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

New products from Purina and BI target stress in veterinary patients

December 11, 2018
dvm360, dvm360 January 2019, Volume 50, Issue 1

New anxiety relief products for dogs can improve stressful situations

Canine anxiety causes stress for both pets and owners, but two new products can provide relief for this common condition. Purina Pro Plan Veterinary Diets has launched a probiotic supplement-Calming Care-for managing anxiety, and the FDA's Center for Veterinary Medicine has also approved Boehringer Ingelheim's Pexion (imepitoin tablets) to treat noise aversion in dogs, according to releases from both companies.

Purina's Calming Care targets anxiety at the gut, using the probiotic strain Bifidobacterium longum (BL999). According to Purina research scientist Ragen T.S. McGowan, PhD, “Scientific evidence has shown that manipulating gut bacteria through probiotic administration can have a positive influence on anxious behavior in both rats and humans.”

The Purina Pet Care Center conducted a 15-week blinded, placebo-controlled crossover study, which administered BL999 to 24 Labrador retrievers that exhibited anxious behaviors. Over 90 percent of dogs showed improvement in their anxious behaviors over the course of the study, the release states.

“In addition, dogs in the study showed reduced salivary cortisol concentration, decreases in heart rate and increases in heart rate variability in response to various stimuli-all of which were considered physiologic evidence of improvement,” Dr. McGowan explained in the release.

To maintain calm behavior, Calming Care requires ongoing use and is packaged in sachets for once-daily administration.

Advertisement

Pexion, manufactured by Boehringer Ingelheim, specifically treats anxious behavior caused by noise aversion. Dogs with noise aversion may become distressed after hearing loud noises like fireworks, traffic and gun shots, and they will react by hiding, vocalizing, panting, shaking or trembling, vomiting, urinating or defecating, according to the company release. 

A study of dogs that had previously demonstrated noise aversion behaviors during fireworks evaluated Pexion's effectiveness. Owners of 66 percent of the dogs receiving Pexion rated the treatment effect as excellent or good, while owners of 25 percent of dogs receiving the placebo rated the drug reported the same effect, the release notes.

Pexion is available in 100-mg or 400-mg scored tablets, and should be given to the pet twice daily beginning two days before an expected noise event-such as the Fourth of July or New Year's Eve-and continued through the event.

Common adverse reactions observed in the study include difficulty standing and walking, increased appetite, lethargy and vomiting. Of 90 dogs that received Pexion as part of the study, three pet owners reported that their dogs exhibited aggressive behaviors while taking the drug, according to the release.

Pexion will be available by prescription only.

download issueDownload Issue: dvm360 January 2019

Related Content:

BehaviorBreaking Newsdvm360 January 2019
Discussing the significance of puppy socialization with clients
Discussing the significance of puppy socialization with clients
Touching the untouchables: The first reactive referral center for pets with behavioral challenges
Touching the untouchables: The first reactive referral center for pets with behavioral challenges
Helping clients better understand their pets
Helping clients better understand their pets

Advertisement

Latest News

Pet Advocacy Network honors outstanding contributions to the pet care community

Traditional and holistic treatments for giardia

ASU trustees approve the creation of a new veterinary school

6 tips for first-time dog owners

View More Latest News
Advertisement